Seeking Alpha

Shares of Affymax (AFFY -9.1%) become unhinged with a sudden 17% nosedive before they track back...

Shares of Affymax (AFFY -9.1%) become unhinged with a sudden 17% nosedive before they track back up again. Much of the speculation over the company has centered on whether its anemia drug Peginesatide will land FDA approval.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)